-
-
-
-
-
-
-
Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Form S-3 Tempest Therapeutics,
71,379 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

